miimi 
HAKKtSOM A. WlLAJAMS. Jtt^ HJ., CHAIRMAN 
• MNOOLFM, W. VA. 
€ RCIX. RJ. 
M. R1NNCOY. MASS. 
NCLVM. W1S. 
monoali, minn. 
lACtnON. MO. 
wo«, calif. 
D. HATHAWAY. MAINE 
URKIM. N.H. 
jacoo k. ja vrr*. n.v. 
RICHANO S. SCMWCiKCR. PA. 
mcmtmr taft. jr.. ohio 
J. C4_£*X a£AlX. in.. MO. 
•©•ART T. »TA/roNO. VT. 
FAUC LAXAL.T. NfV. 
OOMAE.O ILISMNO. 6f RA1_ COUMSfL 
‘“"JORlI M. WHJTTAKI*. CNICF CLARK 
QICnHcb ^Sfafcs ,-2>cna£e 
COMMITTEE ON 
LABOR AND PUBLIC WELFARE 
WASHINGTON. D.C. 20510 
July 22, 1976 
Donald S. Fredrickson, M.D. 
Director 
National Institutes of Health 
Bethesda, Maryland 20014 
Dear Dr. Fredrickson: 
Enclosed is a copy of the letter which Senator 
Javits and I today sent to the President regarding imple- 
mentation of the NIH Recombinant DN'A Research Guidelines in 
other Federal agencies and in the private sector. 
I want 
and statesmanli 
the formulation 
pleased at your 
outside the med 
the debate over 
tific community 
will doubtless 
imperative that 
refinements and 
to offer my congratulations on the thorough 
ke job NIH has done thus far with respect to 
of these Guidelines. In particular, I am 
involvement of knowledgeable people from 
ical research and scientific communities. As 
the Guidelines continues in both the scien- 
and in the public at large, the Guidelines 
have to be updated and refined. It will be 
NIH remain sensitive to the need for such 
responsive to the public's concerns. 
In the meantime, we should turn our attent 
implementation of the current Guidelines in all sec 
the research community. The Health Subcommittee is 
to take whatever actions are necessary to this end. 
ion to 
tors of 
prepared 
Edward M. Kennedy, Chairman 
Senate Health Subcommittee 
4 
nclosure 
[ 157 ] 
